Current status of recombinant duck enteritis virus vector vaccine research

Current status of recombinant duck enteritis virus vector vaccine research

Duck enteritis virus (DEV), the pathogen of duck viral enteritis, belongs to the α-herpesvirus subfamily. Like other herpesviruses, it has a large genome with multiple non-coding and non-essential regions for viral replication. It is suitable as a live virus vector for inserting and expressing antig...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wen-Feng Jia, An-Ping Wang, Zhi Wu, Xin-Nuo Lei, Yu-Ting Cheng, Shan-Yuan Zhu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Veterinary Science
Subjects:	duck enteritis virus recombinant vector vaccine genetic modification waterfowl infectious disease immune protection efficacy avian vaccines
Online Access:	https://www.frontiersin.org/articles/10.3389/fvets.2025.1453150/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Use of “ARRIAH-AviFluVac” vaccine in turkeys, geese and ducks
by: N. V. Moroz, et al.
Published: (2024-09-01)

Single dose of recombinant baculovirus vaccine expressing sigma B and sigma C genes provides good protection against novel duck reovirus challenge in ducks
by: Yufei Wang, et al.
Published: (2025-01-01)

Development of a recombinant infectious bronchitis virus vaccine expressing infectious laryngotracheitis virus multiple epitopes
by: Guanming Shao, et al.
Published: (2025-01-01)

Neethling Strain-Based Homologous Live Attenuated LSDV Vaccines Provide Protection Against Infection with a Clade 2.5 Recombinant LSDV Strain
by: Wannes Philips, et al.
Published: (2024-12-01)

Genetics and biological characteristics of duck reoviruses isolated from ducks and geese in China
by: Xiaohong Sun, et al.
Published: (2025-02-01)

Research Note: Establishment of vector system harboring duck RNA polymerase I promoter for avian influenza virus
by: Yunyueng Jang, et al.
Published: (2025-01-01)

Evaluation of humoral immune response and milk antibody transfer in calves and lactating cows vaccinated with inactivated H5 avian influenza vaccine
by: Mohamed Samy Abousenna, et al.
Published: (2025-02-01)

Post-marketing safety surveillance for the recombinant zoster vaccine (Shingrix), vaccine adverse event reporting system, United States, October 2017–April 2024
by: Yamin Shu, et al.
Published: (2025-02-01)

IMMUNOPROPHYLAXIS OF CANINE PARVOVIRAL ENTERITIS
by: A. V. Shatalov, et al.
Published: (2019-01-01)

Modelled Public Health Impact of Introducing Adjuvanted Recombinant Zoster Vaccine into the UK National Immunisation Programme
by: Manjit Hunjan, et al.
Published: (2024-11-01)

Spray vaccination with a safe and bivalent H9N2 recombinant chimeric NDV vector vaccine elicits complete protection against NDV and H9N2 AIV challenge
by: Xiaoquan Wang, et al.
Published: (2025-01-01)

Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5‐included SARS‐CoV‐2 variants than homologous vaccination of mRNA vaccine
by: Dandan Peng, et al.
Published: (2023-04-01)

EPIDEMIOLOGICAL MONITORING OF AVIAN INFLUENZA IN THE REPUBLIC OF CRIMEA
by: D. V. Gadzevich, et al.
Published: (2019-04-01)

Analysis of a case of pilomatricoma in an adolescent after receiving recombinant hepatitis B vaccine (CHO cell) in Beijing of China
by: Li Li, et al.
Published: (2025-12-01)

Development of a Recombinant Omicron BA.1 Subunit Vaccine Candidate in Pichia pastoris
by: Sibel Kalyoncu, et al.
Published: (2025-01-01)

COVID-19 Vaccination-Related Concerns Amongst Healthcare Workers
by: Ammarah Saeed, et al.
Published: (2024-12-01)

Immunogenicity of Type IV Pilin Proteins from <i>Clostridium perfringens</i> in Chickens
by: Audrey Charlebois, et al.
Published: (2025-01-01)

Comparative testing of vaccines based on viruses of genetic lineages G1 and Y280 for their potency against low pathogenic avian influenza H9N2
by: S. V. Frolov, et al.
Published: (2021-08-01)

Plant expression systems for production of recombinant pharmaceutically important proteins
by: E. V. Deineko, et al.
Published: (2018-01-01)

Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications
by: Nimeet Desai, et al.
Published: (2025-02-01)

Chitosan Nanoparticles for Enhanced Immune Response and Delivery of Multi-Epitope <i>Helicobacter pylori</i> Vaccines in a BALB/c Mouse Model
by: Rita Amaral, et al.
Published: (2025-01-01)

Engineering a live-attenuated porcine reproductive and respiratory syndrome virus vaccine to prevent RNA recombination by rewiring transcriptional regulatory sequences
by: Liwei Li, et al.
Published: (2025-02-01)

Optimal control of vaccination dynamics during an influenza epidemic
by: Majid Jaberi-Douraki, et al.
Published: (2014-05-01)

Seasonality and the effectiveness of mass vaccination
by: Dennis L. Chao, et al.
Published: (2015-11-01)

Exploring Future Pandemic Preparedness Through the Development of Preventive Vaccine Platforms and the Key Roles of International Organizations in a Global Health Crisis
by: Jihee Jeon, et al.
Published: (2025-01-01)

Strategic and Technical Considerations in Manufacturing Viral Vector Vaccines for the Biomedical Advanced Research and Development Authority Threats
by: Lindsay A. Parish, et al.
Published: (2025-01-01)

Multiple pathways to evaluate the immunoprotective effect of Turkeys Herpesvirus recombinant vaccine expressing HA of H9N2
by: Wenhao Yang, et al.
Published: (2025-01-01)

The Development of a One-Step PCR Assay for Rapid Detection of an Attenuated Vaccine Strain of Duck Hepatitis Virus Type 3 in Korea
by: Cheng-Dong Yu, et al.
Published: (2024-12-01)

Evaluation of vaccination strategies during pandemic outbreaks
by: Christopher S. Bowman, et al.
Published: (2010-12-01)

The impact of vaccines and vaccinations: Challenges and opportunities for modelers
by: Roy Curtiss III
Published: (2010-12-01)

Cost-efficient assignment panel for ducks. Setup of a cost-efficient assignment panel for duck populations.
by: Chapuis, Hervé, et al.
Published: (2024-09-01)

Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches
by: Carmine D'Amico, et al.
Published: (2025-03-01)

Results of experimental infection of vaccinated and non-vaccinated ducklings with duck hepatitis virus
by: A. A. Chesnokova, et al.
Published: (2022-12-01)

Acute zonal occult outer retinopathy (AZOOR) complex associated with torpedo retinopathy following COVID-19 recombinant mRNA vaccination: a case report of a rare clinical presentation
by: Nai-Wen Chang, et al.
Published: (2025-01-01)

A new vaccination approach for Salmonellosis employing a multi-epitope vaccine based on live microbial cell factory from Lactococcus lactis
by: Reyhaneh Sadat Moosavi-Kohnehsari, et al.
Published: (2025-02-01)

Mucosal Immunization with an Influenza Vector Carrying SARS-CoV-2 N Protein Protects Naïve Mice and Prevents Disease Enhancement in Seropositive Th2-Prone Mice
by: Mariia V. Sergeeva, et al.
Published: (2024-12-01)

Recombinant Anti-PF4 Antibodies Derived from Patients with Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Facilitate Research and Laboratory Diagnosis of VITT
by: Luisa Müller, et al.
Published: (2024-12-01)

Immunogenicity and protective efficacy of a multi-antigenic adenovirus-based vaccine candidate against Mycobacterium tuberculosis
by: Jin-Seung Yun, et al.
Published: (2025-01-01)

Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us?
by: Iván Sanz-Muñoz, et al.
Published: (2025-02-01)

Determinants of Parental Attitudes towards Children’s Vaccination in Lithuania: An Online Survey
by: Kamilė Čeponytė, et al.
Published: (2024-05-01)